What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Fresenius
100%DGNews: Further Research Needed to Determine Safety of Digoxin in Patients on Dialysis
95%DGNews: Prosorba Column Launched in Europe for Rheumatoid Arthritis
90%DGNews: Warfarin Increases Risk of Stroke in Some Patients on Dialysis
85%DGNews: Catumaxomab Increases Time Between Punctures for Draining Malignant Ascites: Presented at ASCO-GI
84%DGNews: Early Intervention Dramatically Improves Outcomes for New Dialysis Patients
83%DGNews: Some Patients on Haemodialysis May Benefit From Improved Serum 25(OH)D Levels: Presented at NKF
82%DGNews: Anti-T-Cell Globulin Reduces Incidence of Acute, Chronic Graft-Versus-Host Disease in Transplant Patients
78%DGNews: Low 1,25 Dihydroxy Vitamin D Linked to Mortality in Hemodialysis Patients: Presented at ASN
77%DGNews: Thrombus Precursor Protein (TpP) Diagnostic Test Cleared by FDA
76%DGNews: FDA Approves Product to Treat Serious Blood Volume Loss following Surgery
75%DGNews: Novel Trifunctional Antibody Offers Potential Treatment for Inoperable Peritoneal Carcinomatosis: Presented at ASCO
75%DGNews: Study Confirms Recommended Dialysis Dose
74%DGNews: Catumaxomab Effective in Treating Malignant Ascites Following Ovarian Cancer: Presented at ASCO
74%DGNews: Mantle Cell Lymphoma is Curable With Intensive Immunochemotherapy: Presented at ASH
73%DGNews: Fractionated Plasma Separation and Adsorption Provides Survival Benefits for Acute-on-Chronic Liver Failure: Presented at EASL 2010
72%DGNews: Efficacy and Safety of Trifunctional Antibody, Catumaxomab, Documented in Phase 2/3 Study: Presented at ASCO
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.